select
search
   
Pharmacotherapy: A Pathophysiologic Approach, 8e

Joseph T. DiPiro, Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, L. Michael Posey


Online Pharmacotherapy Editorial Board:
Executive Editor: Joseph DiPiro; Editors: Robert L. Talbert, Gary C. Yee, Gary R. Matzke, Barbara G. Wells, L. Michael Posey, Terrence Schwinghammer

Preface     Copyright     Contributors


Show All Chapters | Hide All Chapters


Take Interactive Q&A



Glossary
Section 1. Foundation Issues
Section Editor: L. Michael Posey
Chapter 1Pharmacoeconomics: Principles, Methods, and Applications
Chapter 2Health Outcomes and Health-Related Quality of Life
Chapter 3Health Literacy and Medication Use
Chapter 4Cultural Competency
Chapter 5Principles and Practices of Medication Safety
Chapter 6Evidence-Based Medicine
Chapter 7Documentation of Pharmacy Services
Chapter 8Clinical Pharmacokinetics and Pharmacodynamics
Chapter 9Pharmacogenetics
Chapter 10Pediatrics
Chapter 11Geriatrics
Chapter 12Palliative Care
Chapter 13Pharmacoepidemiology
 Chapter 14Clinical Toxicology
Chapter 15Emergency Preparedness: Identification and Management of Biologic Exposures
Chapter 16Emergency Preparedness: Identification and Management of Chemical and Radiologic Exposures
Section 2. Cardiovascular Disorders
Section Editor: Robert L. Talbert
 Chapter 17Cardiovascular Testing
 Chapter 18Cardiac Arrest
 Chapter 19Hypertension
 Chapter 20Systolic Heart Failure
 Chapter 21Diastolic Heart Failure and the Cardiomyopathies
 Chapter 22Acute Decompensated Heart Failure
 Chapter 23Ischemic Heart Disease
 Chapter 24Acute Coronary Syndromes
 Chapter 25The Arrhythmias
 Chapter 26Venous Thromboembolism
 Chapter 27Stroke
 Chapter 28Dyslipidemia
 Chapter 29Peripheral Arterial Disease
 Chapter 30Use of Vasopressors and Inotropes in the Pharmacotherapy of Shock
 Chapter 31Hypovolemic Shock
Section 3. Respiratory Disorders
Section Editor: Robert L. Talbert
Chapter 32Introduction to Pulmonary Function Testing
 Chapter 33Asthma
 Chapter 34Chronic Obstructive Pulmonary Disease
 Chapter 35Pulmonary Arterial Hypertension
 Chapter 36Drug-Induced Pulmonary Diseases
 Chapter 37Cystic Fibrosis
Section 4. Gastrointestinal Disorders
Section Editor: Joseph T. DiPiro
 Chapter 38Evaluation of the Gastrointestinal Tract
 Chapter 39Gastroesophageal Reflux Disease
 Chapter 40Peptic Ulcer Disease
 Chapter 41Inflammatory Bowel Disease
 Chapter 42Nausea and Vomiting
 Chapter 43Diarrhea, Constipation, and Irritable Bowel Syndrome
 Chapter 44Portal Hypertension and Cirrhosis
 Chapter 45Drug-Induced Liver Disease
 Chapter 46Pancreatitis
 Chapter 47Viral Hepatitis
 Chapter 48Drug Therapy Individualization in Patients with Hepatic Disease and Genetic Alterations in Drug Metabolizing Activity
Chapter 49Celiac Disease
Section 5. Renal Disorders
Section Editor: Gary R. Matzke
 Chapter 50Clinical Assessment of Kidney Function
 Chapter 51Acute Kidney Injury
 Chapter 52Chronic Kidney Disease: Progression-Modifying Therapies
 Chapter 53Chronic Kidney Disease: Management of Complications
Chapter 54Hemodialysis and Peritoneal Dialysis
 Chapter 55Drug-Induced Kidney Disease
 Chapter 56Glomerulonephritis
 Chapter 57Drug Therapy Individualization for Patients with Chronic Kidney Disease
 Chapter 58Disorders of Sodium and Water Homeostasis
 Chapter 59Disorders of Calcium and Phosphorus Homeostasis
 Chapter 60Disorders of Potassium and Magnesium Homeostasis
 Chapter 61Acid–Base Disorders
Section 6. Neurologic Disorders
Section Editor: Barbara G. Wells
 Chapter 62Evaluation of Neurologic Illness
 Chapter 63Alzheimer's Disease
 Chapter 64Multiple Sclerosis
 Chapter 65Epilepsy
 Chapter 66Status Epilepticus
 Chapter 67Acute Management of the Brain Injury Patient
 Chapter 68Parkinson's Disease
 Chapter 69Pain Management
 Chapter 70Headache Disorders
Section 7. Psychiatric Disorders
Section Editor: Barbara G. Wells
 Chapter 71Evaluation of Psychiatric Illness
 Chapter 72Childhood Disorders
 Chapter 73Eating Disorders
 Chapter 74Substance-Related Disorders: Overview and Depressants, Stimulants, and Hallucinogens
 Chapter 75Substance-Related Disorders: Alcohol, Nicotine, and Caffeine
 Chapter 76Schizophrenia
 Chapter 77Major Depressive Disorder
 Chapter 78Bipolar Disorder
 Chapter 79Anxiety Disorders I: Generalized Anxiety, Panic, and Social Anxiety Disorders
 Chapter 80Anxiety Disorders II: Posttraumatic Stress Disorder and Obsessive-Compulsive Disorder
 Chapter 81Sleep Disorders
Chapter 82Disorders Associated with Intellectual Disabilities
Section 8. Endocrinologic Disorders
Section Editor: Robert L. Talbert
 Chapter 83Diabetes Mellitus
 Chapter 84Thyroid Disorders
 Chapter 85Adrenal Gland Disorders
 Chapter 86Pituitary Gland Disorders
Section 9. Gynecologic and Obstetric Disorders
Section Editor: Barbara G. Wells
 Chapter 87Pregnancy and Lactation: Therapeutic Considerations
 Chapter 88Contraception
 Chapter 89Menstruation-Related Disorders
 Chapter 90Endometriosis
 Chapter 91Hormone Therapy in Women
Section 10. Urologic Disorders
Section Editor: L. Michael Posey
 Chapter 92Erectile Dysfunction
 Chapter 93Benign Prostatic Hyperplasia
 Chapter 94Urinary Incontinence
Section 11. Immunologic Disorders
Section Editor: Gary C. Yee
 Chapter 95Function and Evaluation of the Immune System
 Chapter 96Systemic Lupus Erythematosus and Other Collagen-Vascular Diseases
 Chapter 97Allergic and Pseudoallergic Drug Reactions
 Chapter 98Solid-Organ Transplantation
Section 12. Rheumatologic Disorders
Section Editor: L. Michael Posey
 Chapter 99Osteoporosis and Other Metabolic Bone Diseases
 Chapter 100Rheumatoid Arthritis
 Chapter 101Osteoarthritis
 Chapter 102Gout and Hyperuricemia
Section 13. Ophthalmic and Otolaryngological Disorders
Section Editor: L. Michael Posey
 Chapter 103Glaucoma
 Chapter 104Allergic Rhinitis
Section 14. Dermatologic Disorders
Section Editor: L. Michael Posey
 Chapter 105Dermatologic Drug Reactions and Common Skin Conditions
 Chapter 106Acne Vulgaris
 Chapter 107Psoriasis
 Chapter 108Atopic Dermatitis
Section 15. Hematologic Disorders
Section Editor: Gary C. Yee
 Chapter 109Anemias
 Chapter 110Coagulation Disorders
 Chapter 111Sickle Cell Disease
 Chapter 112Drug-Induced Hematologic Disorders
Section 16. Infectious Diseases
Section Editor: Joseph T. DiPiro
 Chapter 113Laboratory Tests to Direct Antimicrobial Pharmacotherapy
 Chapter 114Antimicrobial Regimen Selection
 Chapter 115Central Nervous System Infections
 Chapter 116Lower Respiratory Tract Infections
 Chapter 117Upper Respiratory Tract Infections
 Chapter 118Influenza
 Chapter 119Skin and Soft-Tissue Infections
 Chapter 120Infective Endocarditis
 Chapter 121Tuberculosis
 Chapter 122Gastrointestinal Infections and Enterotoxigenic Poisonings
 Chapter 123Intraabdominal Infections
 Chapter 124Parasitic Diseases
 Chapter 125Urinary Tract Infections and Prostatitis
 Chapter 126Sexually Transmitted Diseases
 Chapter 127Bone and Joint Infections
 Chapter 128Severe Sepsis and Septic Shock
 Chapter 129Superficial Fungal Infections
 Chapter 130Invasive Fungal Infections
 Chapter 131Infections in Immunocompromised Patients
 Chapter 132Antimicrobial Prophylaxis in Surgery
 Chapter 133Vaccines, Toxoids, and Other Immunobiologics
 Chapter 134Human Immunodeficiency Virus Infection
Section 17. Oncologic Disorders
Section Editor: Gary C. Yee
 Chapter 135Cancer Treatment and Chemotherapy
 Chapter 136Breast Cancer
 Chapter 137Lung Cancer

 Chapter 138Colorectal Cancer
 Chapter 139Prostate Cancer
 Chapter 140Lymphomas
 Chapter 141Ovarian Cancer
 Chapter 142Acute Leukemias
 Chapter 143Chronic Leukemias
 Chapter 144Multiple Myeloma
Chapter 145Myelodysplastic Syndromes
Chapter 146Renal Cell Carcinoma
 Chapter 147Melanoma
 Chapter 148Hematopoietic Stem Cell Transplantation
Section 18. Nutritional Disorders
Section Editor: Gary R. Matzke
 Chapter 149Assessment of Nutrition Status and Nutrition Requirements
 Chapter 150Medication Administration Considerations with Specialized Nutrition Support
 Chapter 151Parenteral Nutrition
 Chapter 152Enteral Nutrition
 Chapter 153Nutritional Considerations in Major Organ Failure
 Chapter 154Obesity


Appendix



 The e-chapter logo indicates a chapter that is currently available only online.


[Back to top]

Pharmacotherapy Updates

4/29/2013: Canagliflozin: A New Agent and Class for the Treatment of Type 2 Diabetes Berlie, Helen; Salinitri, Francine

4/26/2013: Low-Dose Colchicine for Secondary Prevention of Cardiovascular Disease: Results of the LoDoCo Trial   Talbert, Robert

4/24/2013: Ziv-aflibercept: A New Therapeutic Option for Select Patients with Metastatic Colorectal Cancer Arp, Christopher

View All Updates

Videos

Education Guides

Free downloadable PowerPoint presentations for study and group viewing.
Usage guidelines | PowerPoint viewer